Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)
Clinical trial NCT02903160 · COMPLETED
Trial details
- NCT number
- NCT02903160
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-13
- Primary completion
- 2021-11-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.